Funded Artificial Intelligence Startups in Paris
Paris-based AI startups collected rounds at every stage across the roughly two-year window in this dataset, from September 2023 through October 2025.
Paris-based AI startups collected rounds at every stage across the roughly two-year window in this dataset, from September 2023 through October 2025. Seed is the dominant stage — 21 of the 50 entries carry that label — but three Series C closings define the upper boundary: Mistral AI's $2.0B in September 2025, AKUR8's $120M in September 2024, and Nabla's $70M in June 2025.
Two vertical clusters appear repeatedly. Healthcare AI accounts for at least five entries — Nabla, AZmed, Gleamer, Spotlight Medical, and Bioptimus — spanning Seed through Series C. Insurance and financial data AI shows up in the largest checks outside Mistral: AKUR8 and 73 Strings ($55M Series B, February 2025). Activity has been concentrated in 2025: 18 of the 50 rounds closed in the first ten months of that year, including Veesion's Series B ($43M, May 2025), the Orasio seed ($18M, May 2025), and Probabl's seed ($15M, October 2025). All 50 companies are headquartered in Paris, Ile-De-France.
Most recent rounds
50 shownRelated listings
Frequently asked
What are the five largest disclosed rounds among Paris AI startups in this data?
Mistral AI leads with a $2.0B Series C closed September 2025, followed by AKUR8 at $120M Series C (September 2024), Nabla at $70M Series C (June 2025), 73 Strings at $55M Series B (February 2025), and Veesion at $43M Series B (May 2025). The next tier includes Bioptimus at $41M Series A (January 2025) and Orasio at $18M Seed (May 2025).
Which funding stage is most common among Paris AI companies in this dataset?
Seed rounds appear 21 times out of 50 entries, making them the most frequent stage by a wide margin. Pre-seed accounts for 6 more, giving early-stage deals a combined majority. Series A appears 5 times, while Series B and C account for 2 and 3 rounds respectively.
Do any vertical sub-sectors cluster noticeably within Paris AI funding here?
Healthcare and clinical AI is the clearest cluster — Nabla, AZmed, Gleamer, Spotlight Medical, and Bioptimus all raised between late 2023 and mid-2025, with sizes ranging from Seed to a $70M Series C. Insurance and financial data AI forms a second group, anchored by AKUR8 ($120M Series C) and 73 Strings ($55M Series B).
How does 2025 deal activity compare to 2024 in this data?
Eighteen of the 50 rounds closed in 2025 through October, versus 24 in full-year 2024 and 8 in the partial 2023 window shown here. The 2025 cohort contains the two largest rounds in the dataset — Mistral AI's $2.0B and Nabla's $70M — alongside at least nine seed-stage deals.
How many rounds carry undisclosed amounts, and which companies?
Four entries list undisclosed amounts: Beink Dream (Series Unknown, June 2025), Cogny (Seed, December 2024), Pathway (Seed, October 2024), and Giskard (Series Unknown, May 2024). Each has a confirmed round date and stage classification but no published figure.
What is the typical deal size for seed rounds in this Paris AI data?
Most seed rounds land between $2M and $9M. Representative examples include Noota ($3M, May 2025), Argil ($4M, November 2024), Entalpic ($9M, September 2024), and Comand AI ($9M, December 2024). The outlier at the top of the seed range is Orasio at $18M (May 2025); the floor sits around $1M for entries like Fentech and Mister IA.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.